Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/33389
Full metadata record
DC FieldValueLanguage
dc.contributor.authorColeman, Timen_UK
dc.contributor.authorClark, Mirandaen_UK
dc.contributor.authorWelch, Charlieen_UK
dc.contributor.authorWhitemore, Rachelen_UK
dc.contributor.authorLeonardi-Bee, Joen_UK
dc.contributor.authorCooper, Sueen_UK
dc.contributor.authorHewitt, Catherineen_UK
dc.contributor.authorJones, Matthewen_UK
dc.contributor.authorSutton, Stephenen_UK
dc.contributor.authorWatson, Judithen_UK
dc.contributor.authorDaykin, Karenen_UK
dc.contributor.authorUssher, Michaelen_UK
dc.contributor.authorParrott, Steveen_UK
dc.contributor.authorNaughton, Felixen_UK
dc.date.accessioned2021-10-07T07:14:02Z-
dc.date.available2021-10-07T07:14:02Z-
dc.date.issued2022-04en_UK
dc.identifier.urihttp://hdl.handle.net/1893/33389-
dc.description.abstractAims To test efficacy of “MiQuit’, a tailored, self-help, text message stop smoking programme for pregnancy, as an adjunct to usual care (UC) for smoking cessation in pregnancy. Design Multicentre, open, two-arm, parallel-group, superiority randomised controlled trial (RCT) and a Trial Sequential Analysis (TSA) meta-analysis combining trial findings with two previous ones. Setting 24 English hospital antenatal clinics. Participants 1002 pregnant women who were ≥16 years old, were ≤ 25 weeks gestation, and smoked ≥ one daily cigarette and accepted information on cessation with no requirement to set quit dates. Interventions UC or UC plus ‘MiQuit’: 12 weeks of tailored, smoking cessation text messages focussed on inducing and aiding cessation. Measurements Primary outcome: biochemically-validated cessation between 4 weeks after randomisation and late pregnancy. Secondary outcomes: shorter and non-validated abstinence periods, pregnancy outcomes and incremental cost-effectiveness ratios. Findings RCT: cessation was 5.19% (26/501) and 4.59% (23/501) in MiQuit and UC groups [adjusted odds ratio (adj OR) for quitting with MiQuit versus UC, 95% confidence interval (CI), 1.15 (0.65 to 2.04)]; other abstinence findings were similar, with higher point estimates. Primary outcome ascertainment was 61.7% (309) and 67.3% (337) in MiQuit and UC groups with 71.1% (54/76) and 69.5% (41/59) abstinence validation rates, respectively. Pregnancy outcomes were similar and the incremental cost per Quality-Adjusted Life Year was -£1,118 (95% CI -£4,806 to £1,911). More MiQuit group women reported making at least one quit attempt (adj OR (95% CI) for making an attempt, 1.50 (1.07 to 2.09). TSA Meta-analysis: This found no significant difference in prolonged abstinence between MiQuit and UC (pooled OR 1.49, adjusted 95% CI 0.62 to 3.60). Conclusions Irrespective of whether they want to try quitting, when offered a tailored, self-help, text message stop smoking programme for pregnancy (MiQuit) as an adjunct to usual care, pregnant women are not more likely to stop smoking until childbirth but they report more attempts at stopping smokingen_UK
dc.language.isoenen_UK
dc.publisherWileyen_UK
dc.relationColeman T, Clark M, Welch C, Whitemore R, Leonardi-Bee J, Cooper S, Hewitt C, Jones M, Sutton S, Watson J, Daykin K, Ussher M, Parrott S & Naughton F (2022) Effectiveness of offering tailored text message, self-help smoking cessation support to pregnant women who want information on stopping smoking: MiQuit3 randomised controlled trial and meta-analysis. Addiction, 117 (4), pp. 1079-1094. https://doi.org/10.1111/add.15715en_UK
dc.rights© 2021 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction. This is an open access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.en_UK
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_UK
dc.subjectpregnancyen_UK
dc.subjectself-helpen_UK
dc.subjectsmoking cessationen_UK
dc.subjecttext messagingen_UK
dc.titleEffectiveness of offering tailored text message, self-help smoking cessation support to pregnant women who want information on stopping smoking: MiQuit3 randomised controlled trial and meta-analysisen_UK
dc.typeJournal Articleen_UK
dc.rights.embargodate2021-10-12en_UK
dc.identifier.doi10.1111/add.15715en_UK
dc.identifier.pmid34636086en_UK
dc.citation.jtitleAddictionen_UK
dc.citation.issn1360-0443en_UK
dc.citation.issn0965-2140en_UK
dc.citation.volume117en_UK
dc.citation.issue4en_UK
dc.citation.spage1079en_UK
dc.citation.epage1094en_UK
dc.citation.publicationstatusPublisheden_UK
dc.citation.peerreviewedRefereeden_UK
dc.type.statusNA - Not Applicable (or Unknown)en_UK
dc.type.statusVoR - Version of Recorden_UK
dc.contributor.funderCancer Research UKen_UK
dc.contributor.funderNational Institute for Health Researchen_UK
dc.author.emailmichael.ussher@stir.ac.uken_UK
dc.citation.date11/10/2021en_UK
dc.contributor.affiliationUniversity of Nottinghamen_UK
dc.contributor.affiliationUniversity of Nottinghamen_UK
dc.contributor.affiliationUniversity of Yorken_UK
dc.contributor.affiliationUniversity of Nottinghamen_UK
dc.contributor.affiliationUniversity of Nottinghamen_UK
dc.contributor.affiliationUniversity of Nottinghamen_UK
dc.contributor.affiliationUniversity of Yorken_UK
dc.contributor.affiliationUniversity of Nottinghamen_UK
dc.contributor.affiliationUniversity of Cambridgeen_UK
dc.contributor.affiliationUniversity of Yorken_UK
dc.contributor.affiliationUniversity of Nottinghamen_UK
dc.contributor.affiliationInstitute for Social Marketingen_UK
dc.contributor.affiliationUniversity of Yorken_UK
dc.contributor.affiliationUniversity of East Angliaen_UK
dc.identifier.isiWOS:000714600800001en_UK
dc.identifier.scopusid2-s2.0-85118493092en_UK
dc.identifier.wtid1761671en_UK
dc.contributor.orcid0000-0002-0995-7955en_UK
dc.date.accepted2021-09-29en_UK
dcterms.dateAccepted2021-09-29en_UK
dc.date.filedepositdate2021-10-06en_UK
rioxxterms.apcnot requireden_UK
rioxxterms.typeJournal Article/Reviewen_UK
rioxxterms.versionVoRen_UK
local.rioxx.authorColeman, Tim|en_UK
local.rioxx.authorClark, Miranda|en_UK
local.rioxx.authorWelch, Charlie|en_UK
local.rioxx.authorWhitemore, Rachel|en_UK
local.rioxx.authorLeonardi-Bee, Jo|en_UK
local.rioxx.authorCooper, Sue|en_UK
local.rioxx.authorHewitt, Catherine|en_UK
local.rioxx.authorJones, Matthew|en_UK
local.rioxx.authorSutton, Stephen|en_UK
local.rioxx.authorWatson, Judith|en_UK
local.rioxx.authorDaykin, Karen|en_UK
local.rioxx.authorUssher, Michael|0000-0002-0995-7955en_UK
local.rioxx.authorParrott, Steve|en_UK
local.rioxx.authorNaughton, Felix|en_UK
local.rioxx.projectProject ID unknown|National Institute for Health Research|http://dx.doi.org/10.13039/501100000272en_UK
local.rioxx.projectProject ID unknown|Cancer Research UK|http://dx.doi.org/10.13039/501100000289en_UK
local.rioxx.freetoreaddate2021-10-12en_UK
local.rioxx.licencehttp://www.rioxx.net/licenses/under-embargo-all-rights-reserved||2021-10-11en_UK
local.rioxx.licencehttp://creativecommons.org/licenses/by/4.0/|2021-10-12|en_UK
local.rioxx.filenameColeman-etal-Addiction-2022.pdfen_UK
local.rioxx.filecount2en_UK
local.rioxx.source1360-0443en_UK
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles

Files in This Item:
File Description SizeFormat 
MiQuit3 paper supplementary material_clean.pdfSupporting Information736.37 kBAdobe PDFView/Open
Coleman-etal-Addiction-2022.pdfFulltext - Published Version1.52 MBAdobe PDFView/Open


This item is protected by original copyright



A file in this item is licensed under a Creative Commons License Creative Commons

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.